Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Liver Cirrhosis Drugs Price Analysis and Strategies 2012-2016 & Forecasts to 2021 - Research and Markets

This image opens in the lightbox

News provided by

Research and Markets

21 Feb, 2017, 16:10 GMT

Share this article

Share toX

Share this article

Share toX

DUBLIN, Feb. 21, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Liver Cirrhosis Drugs Price Analysis and Strategies - 2016" report to their offering.

The latest research Liver Cirrhosis Drugs Price Analysis and Strategies - 2016, provides drug pricing data and benchmarks in the global Liver Cirrhosis market.

The research answers the following questions:

  • What are the key drugs marketed for Liver Cirrhosis and their clinical attributes? How are they positioned in the Global Liver Cirrhosis market?
  • What are the unit prices and annual treatment cost for Liver Cirrhosis therapies in different countries? What are the drug pricing trends and how are they expected to change in the future? How are the drug pricing and reimbursement landscape different by countries?
  • What are the unmet needs in the global Liver Cirrhosis drugs market? What would be the ideal pricing strategy for a new pipeline therapy for Liver Cirrhosis?

Research Scope:

  • Treatment Options - Identify key drugs marketed and prescribed for Liver Cirrhosis including trade name, molecule name, and company
  • Drugs Attributes - Find out the safety, efficacy, and risk benefit for key drugs marketed for Liver Cirrhosis
  • Market Positioning - Identify how drugs are clinically and commercially positioned in the global Liver Cirrhosis market
  • Liver Cirrhosis Drugs Price Analysis - Find out the annual therapy cost and unit price for key drugs marketed
  • Find out how the price advanced from 2012 and forecast to 2021
  • Pricing & Reimbursement Landscape - Find out the pricing and reimbursement landscape
  • Liver Cirrhosis New Drug Pricing - Identify the effective pricing strategy for a new drug launch

This research will help executives

  • Identify clinical attributes of your competitor drugs
  • Find out how the marketed products for Liver Cirrhosis are clinically and commercially positioned
  • Understand the price of your competitor drugs by countries
  • Use Liver Cirrhosis drugs price data for market sizing, drug sales forecast, budgeting, competitive intelligence, HEOR, and reimbursement
  • Find out the pricing and reimbursement landscape by countries
  • Identify the unmet need in global Liver Cirrhosis market
  • Identify the effective pricing for a new drug

Key Topics Covered:

1. Liver Cirrhosis Treatment Options

2. Liver Cirrhosis Drugs Clinical Attributes

3. Liver Cirrhosis Drugs Market Positioning

4. Liver Cirrhosis Drugs Price Analysis

4.1. Liver Cirrhosis Drugs Price Analysis - US

4.2. Liver Cirrhosis Drugs Price Analysis - Germany

4.3. Liver Cirrhosis Drugs Price Analysis - France

4.4. Liver Cirrhosis Drugs Price Analysis - Italy

4.5. Liver Cirrhosis Drugs Price Analysis - Spain

4.6. Liver Cirrhosis Drugs Price Analysis - UK

4.7. Liver Cirrhosis Drugs Price Analysis - Japan

5. Liver Cirrhosis Drugs Price Benchmarks

6. Drug Pricing & Reimbursement Landscape

6.1. Drug Pricing & Reimbursement Landscape - US

6.2. Drug Pricing & Reimbursement Landscape - Germany

6.3. Drug Pricing & Reimbursement Landscape - France

6.4. Drug Pricing & Reimbursement Landscape - Italy

6.5. Drug Pricing & Reimbursement Landscape - Spain

6.6. Drug Pricing & Reimbursement Landscape - UK

6.7. Drug Pricing & Reimbursement Landscape - Japan

7. Liver Cirrhosis Drugs Price Forecast

8. Liver Cirrhosis Market Unmet Needs

9. Liver Cirrhosis New Drug Pricing

10. Research Methodology

Table 1: Liver Cirrhosis Marketed Drugs, Global, 2016

Table 2: Liver Cirrhosis Drugs Clinical Attribute Analysis, Global, 2016

Table 3: Liver Cirrhosis Drugs Unit Price, Global, 2012 - 2016

Table 4: Liver Cirrhosis Drugs Annual Treatment Cost, Global, 2012 - 2016

Table 5: Liver Cirrhosis Drugs Unit Price, US, 2012 - 2016

Table 6: Liver Cirrhosis Drugs Annual Treatment Cost, US, 2012 - 2016

Table 7: Liver Cirrhosis Drugs Unit Price, Germany, 2012 - 2016

Table 8: Liver Cirrhosis Drugs Annual Treatment Cost, Germany, 2012 - 2016

Table 9: Liver Cirrhosis Drugs Unit Price, France, 2012 - 2016

Table 10: Liver Cirrhosis Drugs Annual Treatment Cost, France, 2012 - 2016

Table 11: Liver Cirrhosis Drugs Unit Price, Italy, 2012 - 2016

Table 12: Liver Cirrhosis Drugs Annual Treatment Cost, Italy, 2012 - 2016

Table 13: Liver Cirrhosis Drugs Unit Price, Spain, 2012 - 2016

Table 14: Liver Cirrhosis Drugs Annual Treatment Cost, Spain, 2012 - 2016

Table 15: Liver Cirrhosis Drugs Unit Price, UK, 2012 - 2016

Table 16: Liver Cirrhosis Drugs Annual Treatment Cost, UK, 2012 - 2016

Table 17: Liver Cirrhosis Drugs Unit Price, Japan, 2012 - 2016

Table 18: Liver Cirrhosis Drugs Annual Treatment Cost, Japan, 2012 - 2016

Table 19: Liver Cirrhosis Drugs Price Comparison Benchmarks, Global, 2016

Table 20. Drug Pricing Landscape by Countries, 2016

Table 21: Drug Reimbursement Landscape by Countries, 2016

Table 22: Liver Cirrhosis Drugs Price Forecast, Global, 2016 - 2021

Table 23: Liver Cirrhosis Drugs Price Forecast, US, 2016 - 2021

Table 24: Liver Cirrhosis Drugs Price Forecast, Germany, 2016 - 2021

Table 25: Liver Cirrhosis Drugs Price Forecast, France, 2016 - 2021

Table 26: Liver Cirrhosis Drugs Price Forecast, Italy, 2016 - 2021

Table 27: Liver Cirrhosis Drugs Price Forecast, Spain, 2016 - 2021

Table 28: Liver Cirrhosis Drugs Price Forecast, UK, 2016 - 2021

Table 29: Liver Cirrhosis Drugs Price Forecast, Japan, 2016 - 2021

Table 30: Liver Cirrhosis Market Unmet Needs

Table 31: Liver Cirrhosis New Drugs Pricing, Global, 2016 - 2021

Figure 1: Liver Cirrhosis Drugs Market Positioning, Global, 2016

Figure 2: Liver Cirrhosis Drugs Unit Price, Global, 2012 - 2016

Figure 3: Liver Cirrhosis Drugs Annual Treatment Cost, Global, 2012 - 2016

Figure 4: Liver Cirrhosis Drugs Unit Price, US, 2012 - 2016

Figure 5: Liver Cirrhosis Drugs Annual Treatment Cost, US, 2012 - 2016

Figure 6: Liver Cirrhosis Drugs Unit Price, Germany, 2012 - 2016

Figure 7: Liver Cirrhosis Drugs Annual Treatment Cost, Germany, 2012 - 2016

Figure 8: Liver Cirrhosis Drugs Unit Price, France, 2012 - 2016

Figure 9: Liver Cirrhosis Drugs Annual Treatment Cost, France, 2012 - 2016

Figure 10: Liver Cirrhosis Drugs Unit Price, Italy, 2012 - 2016

Figure 11: Liver Cirrhosis Drugs Annual Treatment Cost, Italy, 2012 - 2016

Figure 12: Liver Cirrhosis Drugs Unit Price, Spain, 2012 - 2016

Figure 13: Liver Cirrhosis Drugs Annual Treatment Cost, Spain, 2012 - 2016

Figure 14: Liver Cirrhosis Drugs Unit Price, UK, 2012 - 2016

Figure 15: Liver Cirrhosis Drugs Annual Treatment Cost, UK, 2012 - 2016

Figure 16: Liver Cirrhosis Drugs Unit Price, Japan, 2012 - 2016

Figure 17: Liver Cirrhosis Drugs Annual Treatment Cost, Japan, 2012 - 2016

Figure 18: Liver Cirrhosis Drugs Price Comparison Benchmarks, Global, 2016

Figure 19: Liver Cirrhosis Drugs Price Forecast, Global, 2016 - 2021

Figure 20: Liver Cirrhosis Drugs Price Forecast, US, 2016 - 2021

Figure 21: Liver Cirrhosis Drugs Price Forecast, Germany, 2016 - 2021

Figure 22: Liver Cirrhosis Drugs Price Forecast, France, 2016 - 2021

Figure 23: Liver Cirrhosis Drugs Price Forecast, Italy, 2016 - 2021

Figure 24: Liver Cirrhosis Drugs Price Forecast, Spain, 2016 - 2021

Figure 25: Liver Cirrhosis Drugs Price Forecast, UK, 2016 - 2021

Figure 26: Liver Cirrhosis Drugs Price Forecast, Japan, 2016 - 2021

Figure 27: Liver Cirrhosis New Drugs Pricing, Global, 2016 - 2021

For more information about this report visit http://www.researchandmarkets.com/research/svcs2n/liver_cirrhosis

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.